Claims for Patent: 7,214,804
✉ Email this page to a colleague
Summary for Patent: 7,214,804
Title: | Heterocyclic compounds useful as growth hormone secretagogues |
Abstract: | The present invention relates to novel heterocyclic compounds, according to Formula I, that stimulate endogenous production and/or release of growth hormone, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and X are defined herein. Further, the present invention relates to methods for using such compounds and to pharmaceutical compositions containing such compounds ##STR00001## |
Inventor(s): | Zhai; Weixu (Middletown, CT), Gerritz; Samuel (Guilford, CT), Andres, Jr.; Charles John (Wethersfield, CT), Tino; Joseph A. (Lawrenceville, NJ) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 11/033,649 |
Patent Claims: | 1. A compound according to Formula I: ##STR00044## wherein, R.sub.1 at each occurrence is independently selected from the group consisting of hydrogen, alkyl, aryl, hydroxy,
oxyalkyl, oxyperfluoroalkyl halo, amino, carboaminoalkyl, aminocarboalkyl and carboaminocarboalkyl, wherein each alkyl, aryl, oxyalkyl, amino, carboaminoalkyl, aminocarboalkyl and carboaminocarboalkyl, may optionally be substituted with one or more
alkyl, aryl, hydroxy, oxyalkyl, oxyperfluroalkyl, halo, amino, carboaminoalkyl, aminoarboalkyl or carboaminocarboalkyl; R.sub.2 is selected from the group consisting of H and alkyl; R.sub.3 at each occurrence is independently selected from the group
consisting of hydrogen, alkyl and halo; R.sub.4 is selected from the group consisting of H and alkyl; X is (CH.sub.2).sub.n; and n is 0 or 1, wherein Formula I is inclusive of all prodrugs, prodrug esters, stereoisomers and pharmaceutically acceptable
salts of Formula I.
2. The compound according to claim 1, wherein: R.sub.1 at each occurrence is independently selected from the group consisting of hydrogen, alkyl, aryl, oxyalkyl, oxyperfluoroalkyl and aminocarboalkyl. 3. A pharmaceutical composition, comprising at least one compound according to claim 1; and at least one pharmaceutically acceptable adjuvant or carrier. 4. The pharmaceutical composition according to claim 3, further comprising: at least one additional therapeutic agent selected from the group consisting of other compounds of formula I, parathyroid hormone, bisphosphonates, estrogen, testosterone, selective estrogen receptor modulators, selective androgen receptor modulators, progestin receptor agonists, anti-diabetic agents, anti-hypertensive agents, anti-inflammatory agents, anti-osteoporosis agents, anti-obesity agents, cardiac glycosides, cholesterol lowering agents and thyroid mimetics. 5. The pharmaceutical composition according to claim 3, further comprising at least one nutritional supplement. |
Details for Patent 7,214,804
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2024-01-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.